References
- Basedow KA, Die Glot zaugen (1948): Wochenschr Gesellsch Heilkunde 49:769–772.
- Borgen PI, Wong GY, Vlamis V, Potter CH, Hoffmann B, Kinne DW, Osborne MP, Mckinnon WMP (1992): Current management of male breast cancer: a review of 104 cases. Ann Surg 215:451–459.
- Crichlow RW (1992): Carcinoma of the male breast. Surg Gynecol Obstet 134:1011–1015.
- Drukker BH (1994): Fibrocystic change of the breast. Clin Obstet Gynecol 37:903–915.
- Everson RB, Lippmann ME, Thompson EB (1980): Clinical correlation of steroid receptors and male breast cancer. Cancer Res 40:991–996.
- Guinee VF, Olsson H, Mollen T, Shallenberger RC, van den Blink JW, Peter Z, Durand M, Dische S, Cleton FJ, Zewvster R, Warrenlane MFC, Richter R (1993): The prognosis of breast cancer in males. Cancer 71:154–161.
- Joshi MG, Lee AKC, Loda M, Camus MG, Pedersen C, Heatley GJ, Hughes KS (1996): Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome. Cancer 77:490–498.
- Levin E, Actis AM, Lopez S (1993): Characterization of rat uterine estrogen receptors in vivo. J Steroid Biochem Molec Biol 44:277–285.
- Lowry OH, Rosebrough NJ, Farr AL, Randall AJ (1951): Protein measurement with the folin phenol reagent. J Biol Chem 193:265–275.
- Loza MC, Lemus AE, Perez Palacios G (1995): Metabolismo de hormonas esteroides Bioquimica. Diaz Sagoya-Hicks. Mexico: Interamericana McGraw-Hill, pp 605–639.
- Mabuchi K, Bross DS, Kessler 11 (1985): Risk factors for male breast cancer. JNCI J Natl Cancer Inst 74:371–376.
- Pegoraro RJ, Nirmul D, Joubert SM (1982): Cytoplasmic and nuclear estrogen and progesterone receptors in male breast cancer. Cancer Res 42:4812–4817.
- Perez Palacios G, Larrea F, Cerbón MA, Vilchis F (1995): Mecanismo de acción de hormonas esteroideas. Bioquimica. Diaz Sagoya-Hicks. Mexico: Interamericana McGraw-Hill, pp 640–666.
- Pritchard TJ, Pankowesky DA, Crowe JP (1988): Breast cancer in a male-to-female transsexual. JAMA 259:2278–2280.
- Salazar EL, Gonzalez SJ, Galindo VA, Calzada SL (1996): Estrogen receptor in dysplastic and malig-nant cervical tissue: expression, localization and prognostic significance. Med Sci Res 24:523–524.
- Salazar EL, Roman AM, Gonzalez SJ (1997): Progesterone receptor values in human papillomavirus infection and cervical intraepithelial neoplasia. Med Sci Res 25:511–512.
- Salazar EL, Avila A, Ocampo L, Gonzalez SJ (1998): Estradiol and progesterone receptors values in breast fibroadenoma: an evaluation in overweight patients. Adv Reprod 1:163–167.
- Sanfilippo JS, Miseljic S, Yang A, Doering DL, Shaheen RM, Wittliff JL (1996): Quantitative analy-sis of epidermal growth factor receptor, HER-2/neu oncoprotein and cathepsin D in non-malignant and malignant uteri. Cancer 77:710–716.
- Scatchard G (1949): The attraction of proteins for small molecules and ions. Ann NY Acad Sci 51:660–672.
- Wilson SE, Hutchinson WB (1976): Breast masses in males with carcinoma of prostate. J Surg Oncol 8:105–112.
- Wittliff IL (1974): Specific receptors of the steroid hormones in breast cancer. Semin Oncol 1:109–118.